Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Biotech Growth Trust (the) Plc LSE:BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change % Change Share Price Shares Traded Last Trade
  24.00 2.99% 828.00 25,939 16:35:01
Bid Price Offer Price High Price Low Price Open Price
830.00 835.00 834.00 812.00 812.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 1.08 0.16 339
Last Trade Time Trade Type Trade Size Trade Price Currency
17:58:54 O 853 827.999 GBX

Biotech Growth (BIOG) Latest News (2)

More Biotech Growth News
Biotech Growth Investors    Biotech Growth Takeover Rumours

Biotech Growth (BIOG) Discussions and Chat

Biotech Growth Forums and Chat

Date Time Title Posts
17/6/202215:53Biotech Growth Trust PLC (The)363

Add a New Thread

Biotech Growth (BIOG) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Biotech Growth trades in real-time

Biotech Growth (BIOG) Top Chat Posts

DateSubject
01/7/2022
09:20
Biotech Growth Daily Update: Biotech Growth Trust (the) Plc is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker BIOG. The last closing price for Biotech Growth was 804p.
Biotech Growth Trust (the) Plc has a 4 week average price of 750p and a 12 week average price of 725p.
The 1 year high share price is 1,444p while the 1 year low share price is currently 725p.
There are currently 40,921,729 shares in issue and the average daily traded volume is 58,447 shares. The market capitalisation of Biotech Growth Trust (the) Plc is £338,831,916.12.
14/6/2022
15:47
daveoz1: Quote from above "By the standards of 2008 / 2009, this little Investment Trust has had a reasonably decent year". !!! What does that mean? When was that written? Am I missing something? Since March 2021, the Biotech Growth Trust price has plummeted by 50%! My worst investment by far.
09/12/2021
11:31
steeplejack: Questor in Daily Telegraph (9 Dec) recommends BIOG after marked underperformance in 2021.
29/11/2021
19:03
steeplejack: Oh dear,not popular comments i see.Thing is,over the last five years,BIOG is up 57%,over the same period SMT is up 375%.Investment is about opportunity cost as we all know.Now compared with Astra or Pfizer,the underperformance is that much less,over five years the former is up 97% and the latter up 77%.(Generously,i217;m ignoring management costs attaching to BIOG.)I’m really trying to justify why,on its track record,i should continue to hold this trust especially given its rather ‘risk averse’construct.It appears to be a rather broad simple proxy for biotech per se which means even a major success of one of the constituents is unlikely to meaningful alter the NAV.
28/7/2021
16:47
daveoz1: Absolutely ali47fish - I did a lot of investing about 4 months ago and BIOG has been by far the worst performing fund of those that I bought then, especially in the last few days! Finding it very hard to find out reasons for this. Slightly better today, but I'm hoping it improves a LOT more!
16/7/2021
11:52
tomps2: John Rosier mentions Biotech Growth (BIOG) in the latest PIWORLD interview at 12m14s Watch the video here: Https://www.piworld.co.uk/education-videos/piworld-interview-john-rosiers-portfolio-update-july-2021/ Or listen to the podcast here: Https://piworld.podbean.com/e/piworld-interview-john-rosiers-portfolio-update-july-2021/
09/6/2021
07:11
steeplejack: 2.5% of BIOG portfolio represented by Biogen which jumped some 40% in the US yesterday following FDA approval of its Alzheimer drug.
06/3/2021
19:31
cliff007: Ali. That's what I meant. I'm wondering what's going on. Another Investment Trust I have WWH, has suffered the same fate so I don't believe it's BIOG specific. I'm holding on.....
06/3/2021
18:41
shaker44: Could go lower of course. Markets jittery. But price now will look low later this year imo
12/12/2020
20:17
caradog: AstraZeneca to take over Alexion, which was BIOGs biggest holding on 31 Oct at 5.1% of the portfolio when Alexion’s share price was about $114. The cash and share deal is worth about $175 - a 45% premium on last quoted price.
29/7/2019
16:56
rogerrail: IBT on slight premium to NAV whereas BIOG at a discount . Very similar funds, I would expect BIOG to catch up at some point
Biotech Growth share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
BIOG
Biotech Gr..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220701 17:48:12